Low RAI2 expression is a marker of poor prognosis in breast cancer.
Sayaka NishikawaYasuaki UemotoTae-Sun KimTomoka HisadaNaoto KondoYumi Wanifuchi-EndoTakashi FujitaTomoko AsanoYusuke KatagiriMitsuo TeradaAkiko KatoYu DongHiroshi SugiuraKatsuhiro OkudaHiroyuki KatoSatoshi OsagaSatoru TakahashiTatsuya ToyamaPublished in: Breast cancer research and treatment (2021)
Our findings suggest that RAI2 has a role in the metastasis of breast cancer, and that RAI2 expression could be a promising candidate biomarker of prognosis in breast cancer patients.